HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donna J Hicks Selected Research

VU661013

9/2019Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donna J Hicks Research Topics

Disease

13Neoplasms (Cancer)
12/2020 - 11/2005
10Breast Neoplasms (Breast Cancer)
09/2019 - 10/2013
3Melanoma (Melanoma, Malignant)
09/2012 - 08/2010
2Neoplasm Metastasis (Metastasis)
12/2020 - 06/2017
2Triple Negative Breast Neoplasms
01/2018 - 06/2017
1Necrosis
01/2019
1Residual Neoplasm
01/2019
1Infections
01/2018
1Cystitis
01/2018
1Disease Progression
01/2018
1Urolithiasis
01/2018
1Adenocarcinoma
11/2005
1Vascular Remodeling
11/2005

Drug/Important Bio-Agent (IBA)

5Phosphotransferases (Kinase)IBA
01/2018 - 09/2012
4Estrogen ReceptorsIBA
09/2019 - 10/2013
4Phenobarbital (Luminal)FDA Link
01/2018 - 10/2013
3Pharmaceutical PreparationsIBA
12/2020 - 10/2013
3Proteins (Proteins, Gene)FDA Link
09/2019 - 01/2017
3Lapatinib (GW572016)FDA Link
01/2019 - 05/2012
3Mechanistic Target of Rapamycin Complex 2IBA
01/2018 - 01/2016
2navitoclaxIBA
09/2019 - 01/2018
2CytokinesIBA
01/2019 - 11/2018
2Messenger RNA (mRNA)IBA
01/2018 - 08/2010
2Estrogens (Estrogen)FDA Link
01/2018 - 01/2018
2Fulvestrant (Faslodex)FDA Link
01/2018 - 10/2013
2Mechanistic Target of Rapamycin Complex 1IBA
01/2018 - 01/2016
2LigandsIBA
10/2013 - 11/2005
1Thromboxane Receptors (Thromboxane Receptor)IBA
12/2020
1cadherin 5IBA
12/2020
1EverolimusFDA Link
09/2019
1VU661013IBA
09/2019
1c-Mer Tyrosine KinaseIBA
01/2019
1NucleotidesIBA
11/2018
1ChemokinesIBA
11/2018
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2018
1Therapeutic UsesIBA
11/2018
1EnzymesIBA
01/2018
1StruviteIBA
01/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1Aromatase InhibitorsIBA
01/2018
1human ERBB2 proteinIBA
06/2017
1A-factor (Streptomyces)IBA
06/2017
1rho Guanine Nucleotide Dissociation Inhibitor betaIBA
06/2017
1CaspasesIBA
01/2017
1Trastuzumab (Herceptin)FDA Link
10/2013
1Caspase 3 (Caspase-3)IBA
10/2013
1tyrosine receptor (receptor, tyrosine)IBA
10/2013
1Biological ProductsIBA
10/2013
1Estrogen Receptor Modulators (Antiestrogen)IBA
10/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2012
1TAK 733IBA
09/2012
1Tyrosine Kinase InhibitorsIBA
05/2012
1Monophenol Monooxygenase (Tyrosinase)IBA
08/2010
1DNA (Deoxyribonucleic Acid)IBA
08/2010
1GoldIBA
08/2010
1EphA2 ReceptorIBA
11/2005
1Ephrin-A1 (Ephrin A1)IBA
11/2005

Therapy/Procedure

5Therapeutics
01/2018 - 01/2012
1Immunotherapy
11/2018